Ironwood Pharmaceuticals Inc (NASDAQ:IRWD)
| 12.43 Data as of Jun 18 |  +0.53 / +4.45%Today’s Change | 10.01 Today|||52-Week Range 19.67 | +12.18% Year-to-Date |
Latest IRWD News | Press Releases
| IRWD Launches Constella in Europe - Analyst Blog Jun 17 / Zacks.com | 4 Stocks Underperforming Today In The Health Services Industry Jun 12 / TheStreet.com |
| Short Interest In Ironwood Pharmaceuticals Moves 11% Lower Jun 13 / TheStreet.com |
Today’s Trading
| Previous close | 11.90 |
| Today’s open | 11.95 |
| Day’s range | 11.92 - 12.55 |
| Volume | 1,321,384 |
| Average volume (3 months) | 1,151,323 |
| Market cap | $1.4B |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | -4.62% |
| Earnings growth (this year) | -303.06% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +128.09% |
| P/E ratio | NM |
| Price/Sales | 7.85 |
| Price/Book | 8.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| VVUSVIVUS Inc | -0.25 | -1.78% |
| SNTSSantarus Inc | +0.76 | +3.53% |
| ACORAcorda Therapeutics ... | +0.73 | +2.13% |
| WXWuXi Pharmatech (Cay... | +0.28 | +1.33% |
Data as of 4:01pm ET, 06/18/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | -$0.68 |
| Annual revenue (last year) | $150.2M |
| Annual profit (last year) | -$72.6M |
| Net profit margin | -48.34% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Peter M. Hecht, PhD |
Senior VP, Chief Operating & Financial Officer Michael J. Higgins, MBA |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
